These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16214079)

  • 1. Adoptive immunotherapy: new ways to skin the cat?
    Milone MC; June CH
    Clin Immunol; 2005 Nov; 117(2):101-3. PubMed ID: 16214079
    [No Abstract]   [Full Text] [Related]  

  • 2. Do T cell receptors do it alone?
    van der Merwe PA
    Nat Immunol; 2002 Dec; 3(12):1122-3. PubMed ID: 12447366
    [No Abstract]   [Full Text] [Related]  

  • 3. 4-1BB costimulation of effector T cells for adoptive immunotherapy of cancer: involvement of Bcl gene family members.
    Kroon HM; Li Q; Teitz-Tennenbaum S; Whitfield JR; Noone AM; Chang AE
    J Immunother; 2007; 30(4):406-16. PubMed ID: 17457215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cells.
    Wang LX; Shu S; Plautz GE
    Cancer Res; 2005 Oct; 65(20):9547-54. PubMed ID: 16230420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proline-rich sequence of CD3epsilon controls T cell antigen receptor expression on and signaling potency in preselection CD4+CD8+ thymocytes.
    Mingueneau M; Sansoni A; Grégoire C; Roncagalli R; Aguado E; Weiss A; Malissen M; Malissen B
    Nat Immunol; 2008 May; 9(5):522-32. PubMed ID: 18408722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Making and circumventing tolerance to cancer.
    Kammertoens T; Blankenstein T
    Eur J Immunol; 2009 Sep; 39(9):2345-53. PubMed ID: 19634191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered T and B lymphocyte signaling pathways in lupus.
    Peng SL
    Autoimmun Rev; 2009 Jan; 8(3):179-83. PubMed ID: 18721908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical potential for koff-rate measurement in adoptive immunotherapy.
    Nauerth M; Weissbrich B; Busch DH
    Expert Rev Clin Immunol; 2013 Dec; 9(12):1151-3. PubMed ID: 24215403
    [No Abstract]   [Full Text] [Related]  

  • 10. The CD3 gamma epsilon/delta epsilon signaling module provides normal T cell functions in the absence of the TCR zeta immunoreceptor tyrosine-based activation motifs.
    Pitcher LA; Mathis MA; Young JA; DeFord LM; Purtic B; Wulfing C; van Oers NS
    Eur J Immunol; 2005 Dec; 35(12):3643-54. PubMed ID: 16259006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen choice in adoptive T-cell therapy of cancer.
    Offringa R
    Curr Opin Immunol; 2009 Apr; 21(2):190-9. PubMed ID: 19297140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothesis: TCR signal transduction--A novel tri-modular signaling system.
    Amon MA; Manolios N
    Mol Immunol; 2008 Feb; 45(4):876-80. PubMed ID: 17915329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving antigen-specific tolerance in diabetes: regulating specifically.
    Chen W; Bluestone JA; Herold KC
    Int Rev Immunol; 2005; 24(5-6):287-305. PubMed ID: 16318983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
    Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM
    Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor.
    Zhang T; Barber A; Sentman CL
    Cancer Res; 2006 Jun; 66(11):5927-33. PubMed ID: 16740733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology. Policing the immune system.
    Wickelgren I
    Science; 2004 Oct; 306(5696):596-9. PubMed ID: 15498987
    [No Abstract]   [Full Text] [Related]  

  • 17. Dok-1 and Dok-2 are negative regulators of T cell receptor signaling.
    Yasuda T; Bundo K; Hino A; Honda K; Inoue A; Shirakata M; Osawa M; Tamura T; Nariuchi H; Oda H; Yamamoto T; Yamanashi Y
    Int Immunol; 2007 Apr; 19(4):487-95. PubMed ID: 17329234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical development of T cell receptor gene therapy.
    Bendle GM; Haanen JB; Schumacher TN
    Curr Opin Immunol; 2009 Apr; 21(2):209-14. PubMed ID: 19321326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.
    Pouw NM; Westerlaken EJ; Willemsen RA; Debets R
    J Gene Med; 2007 Jul; 9(7):561-70. PubMed ID: 17471588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer immunotherapy.
    Zhou J; Zhong Y
    Cell Mol Immunol; 2004 Aug; 1(4):247-55. PubMed ID: 16225767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.